Clinical Trial

Pulmonary Fibrosis, Interstitial Lung Disease Clinical Trial 2016-063

[LCID Study Number: 2016-063]

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease With Progressive Phenotype Prospective Outcomes (IPF-PRO/ILD-PRO) Registry

The purpose of this study is to collect data and biological samples that will support future research studies.

Disease/Condition: Pulmonary Fibrosis, Interstitial Lung Disease

Department: Pulmonary and Critical Care

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

View NCT ID 01915511 on

Protocol #: 2016-063

Principal Investigator(s): Timothy N. Liesching

Study Coordinator(s): Yuxiu Lei

Trial Phase: Sponsor Initiated Study Observational